Symbol
|
AFOBIL | ZMAB4V | ZMABJV | ZMAFPV | TRTLTQ | TRULTQ | UZPLTQ | LHNMLK | WNRLTQ | ZMABQV | BGXBKB | LFLBLK | ZMACAV | LCDMLK | YVALTQ | Z09BLZ | ZNZLTQ | HYJEFG | ZYSLTQ | AAJPTQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Barrier Express Certificate | Express Voncert* | Express Voncert* | Express Voncert* | Express Certificate with European Knock-In | Express Certificate with European Knock-In | Express Certificate with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Express Certificate | Express Voncert | Barrier Express Certificate | LUKB Autocallable Multi Barrier Reverse Convertible | Express Voncert* | LUKB Autocallable Multi Barrier Reverse Convertible | Express Certificate | Express Note* | Callable Barrier Reverse Convertible with Catch-up Income | Callable Express Certificate | Express Certificate with European Knock-In | Express Certificate with European Knock-In |
Sous-jacent
|
Bouygues S.A. / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Amgen Inc. / Novartis Sandoz Basket / Novo Nordisk AS (B) / Pfizer Inc. / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | ABB / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG | ABB / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG | ABB / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG | Nestlé / Roche GS | Johnson & Johnson / Nestlé S.A. / Roche AG / Swiss RE AG | Nestlé / Roche GS / Swisscom | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche AG / Swiss RE AG | Baloise N / Compagnie Financière Richemont SA / Julius Baer Group / Lonza Group N / Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche AG / Sika AG / UBS Group AG | Baloise N / Compagnie Financière Richemont SA / Julius Baer Group / Lonza Group N / Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche AG / Sika AG / UBS Group AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
20.07.2027 | 28.08.2025 | 28.08.2025 | 28.08.2025 | 30.03.2026 | 30.03.2026 | 22.09.2025 | 05.09.2024 | 04.09.2024 | 16.03.2026 | 11.12.2025 | 02.10.2025 | 02.10.2025 | 16.10.2026 | 24.03.2028 | 25.03.2027 | 02.04.2025 | 10.04.2025 | 27.05.2025 | 15.01.2026 |
Ratio | - | - | - | - | - | - | - | - | 0,271798 | - | - | - | - | - | - | - | - | - | - | - |
Prix d'exercise
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Demande | 91,48 | 98,00 | 97,40 | 96,40 | 97,27 | 98,69 | 94,40 | 84,04 | 108,40 | 99,30 | 99,34 | 100,11 | 98,50 | 68,61 | 89,82 | 100,30 | 100,11 | 99,82 | 100,22 | 100,47 |
Offre | 92,28 | - | - | - | 98,07 | 99,49 | 0,490 | 84,67 | - | - | 100,14 | 100,86 | - | 69,12 | 90,62 | 101,00 | 100,91 | 100,62 | 101,03 | 101,28 |